The STOP-MED CTRCD Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2031

Conditions
Heart FailureCardiotoxicityCardiac ToxicityAntineoplastics ToxicityCancer
Interventions
OTHER

Stopping Heart Failure Medication(s)

This group will stop their heart failure medication(s) under the supervision of the study team.

Trial Locations (10)

3004

RECRUITING

Baker Heart and Diabetes Institute, Melbourne

02115

RECRUITING

Brigham and Women's Hospital, Boston

T2N 2T9

NOT_YET_RECRUITING

Foothills Medical Centre, Calgary

T6G 1C9

NOT_YET_RECRUITING

Edmonton Clinic Health Academy, Edmonton

R2H 2A6

NOT_YET_RECRUITING

St. Boniface Hospital, Winnipeg

L8L 2X2

NOT_YET_RECRUITING

Hamilton General Hospital, Hamilton

K1Y 4W7

NOT_YET_RECRUITING

University of Ottawa Heart Institute, Ottawa

M5B 1W8

NOT_YET_RECRUITING

St Michael's Hospital, Toronto

M5G2C4

RECRUITING

University Health Network, Toronto

Unknown

NOT_YET_RECRUITING

Barts Health NHS Trust, University College London, London

All Listed Sponsors
collaborator

Unity Health Toronto

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

St. Boniface Hospital

OTHER

collaborator

Ottawa Heart Institute Research Corporation

OTHER

collaborator

University College London Hospitals

OTHER

collaborator

Alberta Health Services, Calgary

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Baker Heart and Diabetes Institute

OTHER

lead

University Health Network, Toronto

OTHER